경제
중도 성향
AstraZeneca stock plunges after late-stage heart drug trial misses its target
Quartz
The British drugmaker lost roughly $27 billion in market value after Wainua failed to reduce cardiovascular deaths and recurring heart events ...
이 뉴스, 어떠셨어요?
한 번의 탭으로 반응을 남겨요 · 로그인 불필요
관련 뉴스
관련 뉴스 제보는 로그인 후 가능합니다.
'economy' 카테고리 뉴스
Quartz의 다른 기사
Trump said the ceasefire was "over" — then said Iran called to make a deal. Chip stocks are bouncing. Markets don't know what to believe
Quartz
Meta is building its first Canadian data center, a $9 billion AI facility in Alberta
Quartz
AstraZeneca stock plunges after late-stage heart drug trial misses its target
Quartz